Last 12 months
Inside the activity.
10 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 5 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 5 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 08, 2018 Filed Jan 9, 2018 22:05 UTC |
White Albert G IIIEVP, CFO & CSO
|
Exercise / conversionCommon Stock | 680 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-001492 · form4.xml · nonDerivative · entry 1 White Albert G III · CIK 0001357705 · EVP, CFO & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2018 Filed Jan 9, 2018 22:00 UTC |
McBride Daniel GEVP, COO & Pres-CooperVision
|
Exercise / conversionRestricted Stock Units · Derivative | 708 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-001490 · form4.xml · derivative · entry 10 McBride Daniel G · CIK 0001368867 · EVP, COO & Pres-CooperVision 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,417 Underlying: Common Stock · 708 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F7 · derivative.exercise_date: 12/9/14 RSU Grant - Vesting Date: The grant vests in equal portions on the following dates: 1/8/16, 1/8/17, 1/8/18, 1/8/19 and 1/8/20. F4 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| January 08, 2018 Filed Jan 9, 2018 22:00 UTC |
McBride Daniel GEVP, COO & Pres-CooperVision
|
Exercise / conversionRestricted Stock Units · Derivative | 834 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-001490 · form4.xml · derivative · entry 9 McBride Daniel G · CIK 0001368867 · EVP, COO & Pres-CooperVision 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 834 Underlying: Common Stock · 834 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F5 · derivative.exercise_date: Grant Date 12/11/13 RSU Vesting Date: The grant vests in equal portions on the following dates: 1/8/15, 1/8/16, 1/8/17, 1/8/18 and 1/8/19. F6 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| January 08, 2018 Filed Jan 9, 2018 22:00 UTC |
McBride Daniel GEVP, COO & Pres-CooperVision
|
Exercise / conversionRestricted Stock Units · Derivative | 680 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-001490 · form4.xml · derivative · entry 8 McBride Daniel G · CIK 0001368867 · EVP, COO & Pres-CooperVision 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 680 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F3 · derivative.exercise_date: Grant Date 12/12/12 RSU Vesting Date: The grant vests in equal portions on the following dates: 1/8/14, 1/8/15, 1/8/16, 1/8/17 and 1/8/18. F4 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| January 08, 2018 Filed Jan 9, 2018 22:00 UTC |
McBride Daniel GEVP, COO & Pres-CooperVision
|
Tax withholdingCommon Stock | 392 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-001490 · form4.xml · nonDerivative · entry 6 McBride Daniel G · CIK 0001368867 · EVP, COO & Pres-CooperVision 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,362 F1 · shares: 1/8/2018 RSU Release: Shares withheld to cover applicable tax obligations. A FMV (closing price of the Company's common stock on 1/8/2018) of $231.65 was used. Read SEC document |
| January 08, 2018 Filed Jan 9, 2018 22:00 UTC |
McBride Daniel GEVP, COO & Pres-CooperVision
|
Exercise / conversionCommon Stock | 708 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-001490 · form4.xml · nonDerivative · entry 5 McBride Daniel G · CIK 0001368867 · EVP, COO & Pres-CooperVision 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2018 Filed Jan 9, 2018 22:00 UTC |
McBride Daniel GEVP, COO & Pres-CooperVision
|
Tax withholdingCommon Stock | 461 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-001490 · form4.xml · nonDerivative · entry 4 McBride Daniel G · CIK 0001368867 · EVP, COO & Pres-CooperVision 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,046 F1 · shares: 1/8/2018 RSU Release: Shares withheld to cover applicable tax obligations. A FMV (closing price of the Company's common stock on 1/8/2018) of $231.65 was used. Read SEC document |
| January 08, 2018 Filed Jan 9, 2018 22:00 UTC |
McBride Daniel GEVP, COO & Pres-CooperVision
|
Exercise / conversionCommon Stock | 834 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-001490 · form4.xml · nonDerivative · entry 3 McBride Daniel G · CIK 0001368867 · EVP, COO & Pres-CooperVision 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2018 Filed Jan 9, 2018 22:00 UTC |
McBride Daniel GEVP, COO & Pres-CooperVision
|
Tax withholdingCommon Stock | 402 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-001490 · form4.xml · nonDerivative · entry 2 McBride Daniel G · CIK 0001368867 · EVP, COO & Pres-CooperVision 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,673 F1 · shares: 1/8/2018 RSU Release: Shares withheld to cover applicable tax obligations. A FMV (closing price of the Company's common stock on 1/8/2018) of $231.65 was used. Read SEC document |
| January 08, 2018 Filed Jan 9, 2018 22:00 UTC |
McBride Daniel GEVP, COO & Pres-CooperVision
|
Exercise / conversionCommon Stock | 680 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-001490 · form4.xml · nonDerivative · entry 1 McBride Daniel G · CIK 0001368867 · EVP, COO & Pres-CooperVision 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2018 Filed Jan 8, 2018 21:18 UTC |
RUBENSTEIN ALLAN EDirector
|
SaleCommon Stock | 500 | $230.05 | $115,025.00 |
DisclosureSEC source: 0001127602-18-001375 · form4.xml · nonDerivative · entry 1 RUBENSTEIN ALLAN E · CIK 0001182773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,590 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.021 to $230.175. The reporting person undertakes to provide to The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. Read SEC document |
| January 04, 2018 Filed Jan 4, 2018 22:35 UTC |
ZINBERG STANLEY MDDirector
|
Exercise / conversionNon-employee Director Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $13.08 | $0.00 |
DisclosureSEC source: 0001127602-18-001181 · form4.xml · derivative · entry 5 ZINBERG STANLEY MD · CIK 0001182041 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Stanley Zinberg Revocable Trust DTD 2/5/2015 Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2018-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2018 Filed Jan 4, 2018 22:35 UTC |
ZINBERG STANLEY MDDirector
|
SaleCommon Stock | 502 | $226.11 | $113,507.22 |
DisclosureSEC source: 0001127602-18-001181 · form4.xml · nonDerivative · entry 4 ZINBERG STANLEY MD · CIK 0001182041 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Stanley Zinberg Revocable Trust DTD 2/5/2015 Disclosed balance after: 9,377 F3 · date: Sale price represents an average sale price between $226.00 and $226.31. Read SEC document |
| January 04, 2018 Filed Jan 4, 2018 22:35 UTC |
ZINBERG STANLEY MDDirector
|
SaleCommon Stock | 1,500 | $225.02 | $337,530.00 |
DisclosureSEC source: 0001127602-18-001181 · form4.xml · nonDerivative · entry 3 ZINBERG STANLEY MD · CIK 0001182041 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Stanley Zinberg Revocable Trust DTD 2/5/2015 Disclosed balance after: 9,879 F2 · price: Sale price represents an average sale price between $225.00 and $225.10. Read SEC document |
| January 04, 2018 Filed Jan 4, 2018 22:35 UTC |
ZINBERG STANLEY MDDirector
|
SaleCommon Stock | 2,998 | $224.23 | $672,241.54 |
DisclosureSEC source: 0001127602-18-001181 · form4.xml · nonDerivative · entry 2 ZINBERG STANLEY MD · CIK 0001182041 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Stanley Zinberg Revocable Trust DTD 2/5/2015 Disclosed balance after: 11,379 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.52 to $224.49. The reporting person undertakes to provide to The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. Read SEC document |
| January 04, 2018 Filed Jan 4, 2018 22:35 UTC |
ZINBERG STANLEY MDDirector
|
Exercise / conversionCommon Stock | 5,000 | $13.08 | $65,400.00 |
DisclosureSEC source: 0001127602-18-001181 · form4.xml · nonDerivative · entry 1 ZINBERG STANLEY MD · CIK 0001182041 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Stanley Zinberg Revocable Trust DTD 2/5/2015 Disclosed balance after: 14,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2018 Filed Jan 4, 2018 22:32 UTC |
RUBENSTEIN ALLAN EDirector
|
SaleCommon Stock | 500 | $225.00 | $112,500.00 |
DisclosureSEC source: 0001127602-18-001177 · form4.xml · nonDerivative · entry 1 RUBENSTEIN ALLAN E · CIK 0001182773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,090 Read SEC document |
| December 27, 2017 Filed Dec 28, 2017 22:28 UTC |
RUBENSTEIN ALLAN EDirector
|
SaleCommon Stock | 500 | $222.00 | $111,000.00 |
DisclosureSEC source: 0001127602-17-035579 · form4.xml · nonDerivative · entry 1 RUBENSTEIN ALLAN E · CIK 0001182773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,590 Read SEC document |
| December 20, 2017 Filed Dec 21, 2017 17:56 UTC |
KALKSTEIN MICHAELDirector
|
GiftCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-035304 · form4.xml · nonDerivative · entry 1 KALKSTEIN MICHAEL · CIK 0001183216 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · The Kalkstein and English Family Trust u/a/d May 18, 2005 Disclosed balance after: 9,136 Read SEC document |
| December 19, 2017 Filed Dec 20, 2017 22:37 UTC |
RUBENSTEIN ALLAN EDirector
|
GiftCommon Stock | 44 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-035281 · form4.xml · nonDerivative · entry 1 RUBENSTEIN ALLAN E · CIK 0001182773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,090 Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 22:43 UTC |
BENDER A THOMASDirector
|
Exercise / conversionNon-employee Director Stock Option (Right to Buy) · Derivative | 7,150 | $0.00 Strike: $49.57 | $0.00 |
DisclosureSEC source: 0001127602-17-035283 · form4.xml · derivative · entry 5 BENDER A THOMAS · CIK 0001182195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,150 shares Expires 2020-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 22:43 UTC |
BENDER A THOMASDirector
|
SaleCommon Stock | 7,150 | $229.07 | $1,637,827.62 |
DisclosureSEC source: 0001127602-17-035283 · form4.xml · nonDerivative · entry 3 BENDER A THOMAS · CIK 0001182195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,205 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.00 to $229.35. The reporting person undertakes to provide The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set for in the footnote to this Form 4. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 22:43 UTC |
BENDER A THOMASDirector
|
Exercise / conversionCommon Stock | 7,150 | $49.57 | $354,425.50 |
DisclosureSEC source: 0001127602-17-035283 · form4.xml · nonDerivative · entry 2 BENDER A THOMAS · CIK 0001182195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 22:43 UTC |
BENDER A THOMASDirector
|
SaleCommon Stock | 2,000 | $229.54 | $459,080.00 |
DisclosureSEC source: 0001127602-17-035283 · form4.xml · nonDerivative · entry 1 BENDER A THOMAS · CIK 0001182195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,205 Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 22:40 UTC |
WEISS ROBERT SDirector · President & CEO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $58.07 | $0.00 |
DisclosureSEC source: 0001127602-17-035282 · form4.xml · derivative · entry 9 WEISS ROBERT S · CIK 0001181959 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2020-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: RSW 12/13/10 NQ 4yr Grant: The options will vest in equal increments over four years measured from the date of grant as follows: 1/4 shall vest on 12/13/11; 1/4 shall vest on 12/13/12; 1/4 shall vest on 12/13/13; and 1/4 shall vest on 12/13/14. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 22:40 UTC |
WEISS ROBERT SDirector · President & CEO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $58.07 | $0.00 |
DisclosureSEC source: 0001127602-17-035282 · form4.xml · derivative · entry 8 WEISS ROBERT S · CIK 0001181959 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,500 shares Expires 2020-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 12/13/10 RSW NQ 5 yr Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/13/11; 1/5 shall vest on 12/13/12; 1/5 shall vest on 12/13/13; 1/5 shall vest on 12/13/14; and 1/5 shall vest on 12/13/15. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 22:40 UTC |
WEISS ROBERT SDirector · President & CEO
|
SaleCommon Stock | 980 | $226.97 | $222,430.60 |
DisclosureSEC source: 0001127602-17-035282 · form4.xml · nonDerivative · entry 6 WEISS ROBERT S · CIK 0001181959 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,611 F4 · price: The sales price represents a weighted average of sales prices ranging between $226.75 and $227.08. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 22:40 UTC |
WEISS ROBERT SDirector · President & CEO
|
SaleCommon Stock | 5,964 | $226.01 | $1,347,923.64 |
DisclosureSEC source: 0001127602-17-035282 · form4.xml · nonDerivative · entry 5 WEISS ROBERT S · CIK 0001181959 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,591 F3 · price: The sales price represents a weighted average of sales prices ranging between $225.75 and $226.605. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 22:40 UTC |
WEISS ROBERT SDirector · President & CEO
|
SaleCommon Stock | 5,929 | $225.17 | $1,335,032.93 |
DisclosureSEC source: 0001127602-17-035282 · form4.xml · nonDerivative · entry 4 WEISS ROBERT S · CIK 0001181959 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,555 F2 · price: The sales price represents a weighted average of sales prices ranging between $224.68 and $225.67. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 22:40 UTC |
WEISS ROBERT SDirector · President & CEO
|
SaleCommon Stock | 19,627 | $224.04 | $4,397,233.08 |
DisclosureSEC source: 0001127602-17-035282 · form4.xml · nonDerivative · entry 3 WEISS ROBERT S · CIK 0001181959 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,484 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.68 to $224.66. The reporting person undertakes to provide to The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 22:40 UTC |
WEISS ROBERT SDirector · President & CEO
|
Exercise / conversionCommon Stock | 10,000 | $58.07 | $580,700.00 |
DisclosureSEC source: 0001127602-17-035282 · form4.xml · nonDerivative · entry 2 WEISS ROBERT S · CIK 0001181959 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 22:40 UTC |
WEISS ROBERT SDirector · President & CEO
|
Exercise / conversionCommon Stock | 22,500 | $58.07 | $1,306,575.00 |
DisclosureSEC source: 0001127602-17-035282 · form4.xml · nonDerivative · entry 1 WEISS ROBERT S · CIK 0001181959 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 17:41 UTC |
PETERSMEYER GARY SDirector
|
SaleCommon Stock | 785 | $229.06 | $179,812.10 |
DisclosureSEC source: 0001127602-17-035062 · form4.xml · nonDerivative · entry 1 PETERSMEYER GARY S · CIK 0001206986 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Gary and Catherine Petersmeyer Trust DTD Disclosed balance after: 1,584 Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:58 UTC |
McBride Daniel GEVP, COO & Pres-CooperVision
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 17,272 | $0.00 Strike: $229.66 | $0.00 |
DisclosureSEC source: 0001127602-17-034683 · form4.xml · derivative · entry 4 McBride Daniel G · CIK 0001368867 · EVP, COO & Pres-CooperVision 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,272 Underlying: Common Stock · 17,272 shares Expires 2027-12-12 F2 · derivative.exercise_date: 12/12/17 Special NQ Grant-3 yr: The options will vest 100% on the third anniversary of the date of grant. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:58 UTC |
McBride Daniel GEVP, COO & Pres-CooperVision
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 21,849 | $0.00 Strike: $229.66 | $0.00 |
DisclosureSEC source: 0001127602-17-034683 · form4.xml · derivative · entry 3 McBride Daniel G · CIK 0001368867 · EVP, COO & Pres-CooperVision 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,849 Underlying: Common Stock · 21,849 shares Expires 2027-12-12 F1 · derivative.exercise_date: 12/12/17 NQ Grant: The options will vest in equal increments on the first through the fifth anniversaries of the date of grant. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 22:00 UTC |
White Albert G IIIEVP, CFO & CSO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 17,272 | $0.00 Strike: $229.66 | $0.00 |
DisclosureSEC source: 0001127602-17-034685 · form4.xml · derivative · entry 3 White Albert G III · CIK 0001357705 · EVP, CFO & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,272 Underlying: Common Stock · 17,272 shares Expires 2027-12-12 F2 · derivative.exercise_date: 12/12/17 Special NQ Grant-3 yr: The options will vest 100% on the third anniversary of the date of grant. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 22:00 UTC |
White Albert G IIIEVP, CFO & CSO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 21,849 | $0.00 Strike: $229.66 | $0.00 |
DisclosureSEC source: 0001127602-17-034685 · form4.xml · derivative · entry 2 White Albert G III · CIK 0001357705 · EVP, CFO & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,849 Underlying: Common Stock · 21,849 shares Expires 2027-12-12 F1 · derivative.exercise_date: 12/12/17 NQ Grant: The options will vest in equal increments on the first through the fifth anniversaries of the date of grant. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:56 UTC |
KAUFMAN CAROL REVP, Sec. & Chief Gov. Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 16,523 | $0.00 Strike: $229.66 | $0.00 |
DisclosureSEC source: 0001127602-17-034682 · form4.xml · derivative · entry 2 KAUFMAN CAROL R · CIK 0001181958 · EVP, Sec. & Chief Gov. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,523 Underlying: Common Stock · 16,523 shares Expires 2027-12-12 F1 · derivative.exercise_date: 12/12/17 NQ Grant: The options will vest in equal increments on the first through the fifth anniversaries of the date of grant. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:54 UTC |
WEISS ROBERT SDirector · President & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 60,322 | $0.00 Strike: $229.66 | $0.00 |
DisclosureSEC source: 0001127602-17-034681 · form4.xml · derivative · entry 3 WEISS ROBERT S · CIK 0001181959 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,322 Underlying: Common Stock · 60,322 shares Expires 2027-12-12 F1 · derivative.exercise_date: 12/12/17 NQ Grant: The options will vest in equal increments on the first through the fifth anniversaries of the date of grant. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:53 UTC |
Golden RandalVP, General Counsel
|
GrantRestricted Stock Units · Derivative | 538 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-034680 · form4.xml · derivative · entry 3 Golden Randal · CIK 0001598001 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 538 Underlying: Common Stock · 538 shares Expires not disclosed F2 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F3 · derivative.exercise_date: 12/12/17 Exec Grant-3 yr cliff: The grant will vest 100% on 2/1/2021. F4 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:53 UTC |
Golden RandalVP, General Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,118 | $0.00 Strike: $229.66 | $0.00 |
DisclosureSEC source: 0001127602-17-034680 · form4.xml · derivative · entry 2 Golden Randal · CIK 0001598001 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,118 Underlying: Common Stock · 8,118 shares Expires 2027-12-12 F1 · derivative.exercise_date: 12/12/17 NQ Grant: The options will vest in equal increments on the first through the fifth anniversaries of the date of grant. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:51 UTC |
Ricupati AgostinoSVP, Fin & Tax; Chief Actg Off
|
GrantRestricted Stock Units · Derivative | 1,023 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-034679 · form4.xml · derivative · entry 4 Ricupati Agostino · CIK 0001710066 · SVP, Fin & Tax; Chief Actg Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,023 Underlying: Common Stock · 1,023 shares Expires not disclosed F3 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F4 · derivative.exercise_date: 12/12/17 RSU Grant - Vesting Date: The grant vests in equal portions on the following dates: 1/8/19, 1/8/20, 1/8/21, 1/8/22 and 1/8/23. F5 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:51 UTC |
Ricupati AgostinoSVP, Fin & Tax; Chief Actg Off
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 2,135 | $0.00 Strike: $229.66 | $0.00 |
DisclosureSEC source: 0001127602-17-034679 · form4.xml · derivative · entry 3 Ricupati Agostino · CIK 0001710066 · SVP, Fin & Tax; Chief Actg Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,135 Underlying: Common Stock · 2,135 shares Expires 2027-12-12 F2 · derivative.exercise_date: 12/12/17 Exec Grant-3 yr cliff: The grant will vest 100% on 2/1/2021. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:51 UTC |
Ricupati AgostinoSVP, Fin & Tax; Chief Actg Off
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 4,059 | $0.00 Strike: $229.66 | $0.00 |
DisclosureSEC source: 0001127602-17-034679 · form4.xml · derivative · entry 2 Ricupati Agostino · CIK 0001710066 · SVP, Fin & Tax; Chief Actg Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 Underlying: Common Stock · 4,059 shares Expires 2027-12-12 F1 · derivative.exercise_date: 12/12/17 NQ Grant: The options will vest in equal increments on the first through the fifth anniversaries of the date of grant. Read SEC document |
| December 05, 2017 Filed Dec 14, 2017 22:43 UTC |
ZINBERG STANLEY MDDirector
|
GiftRestricted Stock Units · Derivative | 1,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-034724 · form4.xml · derivative · entry 3 ZINBERG STANLEY MD · CIK 0001182041 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Stanley Zinberg Revocable Trust DTD 2/5/2015 Disclosed balance after: 1,151 Underlying: Common Stock · 1,151 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED RSU Grant 11/15/17: RSUs will vest and release on the first anniversary of the date of grant 11/15/2018. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| December 05, 2017 Filed Dec 14, 2017 22:43 UTC |
ZINBERG STANLEY MDDirector
|
GiftRestricted Stock Units · Derivative | 1,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-034724 · form4.xml · derivative · entry 2 ZINBERG STANLEY MD · CIK 0001182041 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,151 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED RSU Grant 11/15/17: RSUs will vest and release on the first anniversary of the date of grant 11/15/2018. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| December 05, 2017 Filed Dec 14, 2017 22:41 UTC |
Lindell Jody SDirector
|
GiftRestricted Stock Units · Derivative | 1,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-034722 · form4.xml · derivative · entry 5 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,151 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED RSU Grant 11/15/17: RSUs will vest and release on the first anniversary of the date of grant 11/15/2018. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| December 05, 2017 Filed Dec 14, 2017 22:41 UTC |
Lindell Jody SDirector
|
GiftRestricted Stock Units · Derivative | 1,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-034722 · form4.xml · derivative · entry 4 Lindell Jody S · CIK 0001356151 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Matthews-Lindell Family Trust, dated July 23, 1991 as amended and restated Disclosed balance after: 1,151 Underlying: Common Stock · 1,151 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED RSU Grant 11/15/17: RSUs will vest and release on the first anniversary of the date of grant 11/15/2018. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| December 05, 2017 Filed Dec 14, 2017 22:39 UTC |
KALKSTEIN MICHAELDirector
|
GiftRestricted Stock Units · Derivative | 1,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-034719 · form4.xml · derivative · entry 4 KALKSTEIN MICHAEL · CIK 0001183216 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Kalkstein & English Family Trust u/a/d May 18, 2005, as amended Disclosed balance after: 1,151 Underlying: Common Stock · 1,151 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED RSU Grant 11/15/17: RSUs will vest and release on the first anniversary of the date of grant 11/15/2018. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
| December 05, 2017 Filed Dec 14, 2017 22:39 UTC |
KALKSTEIN MICHAELDirector
|
GiftRestricted Stock Units · Derivative | 1,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-034719 · form4.xml · derivative · entry 3 KALKSTEIN MICHAEL · CIK 0001183216 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,151 shares Expires not disclosed F1 · derivative.exercise_price: RSU Exercise Price: There is no exercise price associated with the grant of Restricted Stock Units. F2 · derivative.exercise_date: NED RSU Grant 11/15/17: RSUs will vest and release on the first anniversary of the date of grant 11/15/2018. F3 · derivative.expiration_date: RSU Expiration Date: This award has no expiration date. Units will either vest or be forfeit. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.